Navigation Links
Coenzyme Q10 may reduce risk of Parkinson's disease

The naturally occurring compound coenzyme Q10 is the first treatment to actually slow down Parkinson's disease, rather than just treating its symptoms. The current treatments for Parkinson's disease// can help alleviate the movement disorders that accompany the condition, but they do not actually stop the underlying brain damage. In Parkinson's, cells in the substantia nigra, at the base of the brain, are slowly destroyed, leading to a number of motor and emotional symptoms.

In a preliminary study, the popular food supplement coenzyme Q10 actually seems to slow down the progress of the disease, as opposed to treating the symptoms. Researchers at the University of California gave a group of 80 people with Parkinson's either a varying dose of coenzyme Q10 (300, 600 or 1200 milligrams a day) or placebo for 16 months, assessing various aspects of their illness every four months.

Those on the highest dose of coenzyme Q10 had far better ratings than those on placebo - being 44 per cent better at the end of the study. The researchers believe that the compound actually slows down the condition, but want to carry out brain imaging studies to confirm this.


'"/>




Page: 1

Related medicine news :

1. New Study to look at the Beneficial Effects of Coenzyme Q10 on Parkinson’s disease
2. Stress reduces your immunity- startling but true!!!!!
3. Risk of Cancer can be reduced to 40% with a High Fiber Diet
4. Thirty minutes of work up per day reduces the risk of Diabetes
5. Aspirin reduces deaths
6. Stop smoking and reduce weight
7. Statins reduce heart attacks
8. Vitamins reduce pre-eclampsia
9. Exercises reduce risks of cancers
10. Frequent meals can reduce cholesterol
11. Tomato Sauce reduces Cancer Risk- Study
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... , ... March 28, 2017 , ... Usually, the impending ... daily wardrobe. However, for those self-conscious about a double chin, this means more anxiety ... ideal solution. , “For most people, a double chin is undesirable,” Dr. Goldman ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm ... its corporate headquarters to a new, more expansive office space in order to ... Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 Silas ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... 28, 2017 , ... AutismOne announced the Board Certified in ... Medicine and available for application on Saturday, May 27, 2017, following Thursday, Friday, ... Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities termed ...
(Date:3/28/2017)... , ... March 28, 2017 , ... With expansion and ... Georgia, in early March. , The seed processing plant opened in Marshallville in 2006, ... 2016. The new office allows opportunity for transition of Patten Seed operations to the ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CAMBRIDGE , United Kingdom and  BOSTON ... text analytics provider Linguamatics today announced ... Dow Jones . The agreement allows pharmaceutical companies ... utilizing Linguamatics I2E text mining technology. ... used by 18 of the top 20 global ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology: